Sign In
Free Newsletter
Metsera falls after accepting up to $10 billion offer from Pfizer
Pfizer wins a $10 billion deal for weight-loss drugmaker Metsera, ending its bidding war with Danish rival Novo Nordisk.
Losses for Big Tech pull Wall Street lower
Wall Street fell as tech giants slide; S&P 500 down 1.2%, Nasdaq drops 2%, Palantir and Nvidia lead losses, Metsera rises.
Novo ups bid to $10B in Metsera fight with Pfizer
Novo Nordisk raised its offer to $10 billion for Metsera, escalating its takeover battle with Pfizer over the drug developer.
Pfizer to buy Metsera in $5B obesity drug deal
Pfizer will acquire Metsera for nearly $5B, boosting its push into obesity treatments with potential oral and injectable drugs.
